Details of the Drug
General Information of Drug (ID: DM3E20L)
Drug Name |
Nagrestipen
|
||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Synonyms | EMIP; BB-10010; ECI-301; Macrophage inflammatory protein 1a, British Biotech; Stem cell protector, British Biotech; MIP-1a, British Biotech; MIP-1 alpha derivatives (cancer), Effector | ||||||||||||||||||||||
Indication |
|
||||||||||||||||||||||
Cross-matching ID | |||||||||||||||||||||||
Molecular Interaction Atlas of This Drug
Drug Therapeutic Target (DTT) |
|
||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Molecular Interaction Atlas (MIA) | |||||||||||||||||||||||||||